Variant report
Variant | nsv971594 |
---|---|
Chromosome Location | chr8:63594002-63596416 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7828204 | chr8:63594050-63594051 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs183493009 | chr8:63594066-63594067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150035731 | chr8:63594086-63594087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565344777 | chr8:63594104-63594105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201518530 | chr8:63594122-63594123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577269895 | chr8:63594137-63594138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541572689 | chr8:63594145-63594146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549014340 | chr8:63594150-63594151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs559681376 | chr8:63594157-63594158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562189735 | chr8:63594195-63594196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs527875045 | chr8:63594220-63594221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530363912 | chr8:63594250-63594251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569573781 | chr8:63594291-63594292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548449644 | chr8:63594309-63594310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563670710 | chr8:63594335-63594336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548140806 | chr8:63594336-63594337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs551780297 | chr8:63594347-63594348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535374565 | chr8:63594369-63594370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187420254 | chr8:63594400-63594401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs367761437 | chr8:63594529-63594530 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs374430473 | chr8:63594603-63594604 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528186242 | chr8:63594605-63594606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546716950 | chr8:63594613-63594614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571140266 | chr8:63594631-63594632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192527061 | chr8:63594677-63594678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535669411 | chr8:63594692-63594693 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs540112185 | chr8:63594747-63594748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557277786 | chr8:63594799-63594800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550216264 | chr8:63594882-63594883 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs34008773 | chr8:63594910-63594911 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569995701 | chr8:63594981-63594982 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77942250 | chr8:63594995-63594996 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114999782 | chr8:63595037-63595038 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs35980983 | chr8:63595049-63595050 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559000816 | chr8:63595050-63595051 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577207352 | chr8:63595097-63595098 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs541162594 | chr8:63595129-63595130 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375791510 | chr8:63595195-63595196 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574916957 | chr8:63595215-63595216 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542031094 | chr8:63595266-63595267 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563609212 | chr8:63595310-63595311 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs7004299 | chr8:63595351-63595352 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs545355553 | chr8:63595415-63595416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563919460 | chr8:63595457-63595458 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs145709759 | chr8:63595567-63595568 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs146878511 | chr8:63595581-63595582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145558500 | chr8:63595582-63595583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555827133 | chr8:63595584-63595585 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572187246 | chr8:63595585-63595586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546358440 | chr8:63595596-63595597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:63572400-63602600 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
2 | chr8:63587400-63602600 | Weak transcription | Fetal Brain Female | brain |
3 | chr8:63594600-63596400 | Enhancers | Fetal Intestine Large | intestine |
4 | chr8:63594800-63595000 | Enhancers | Duodenum Mucosa | Duodenum |
5 | chr8:63594800-63595400 | Enhancers | Right Atrium | heart |
6 | chr8:63594800-63596000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
7 | chr8:63594800-63596400 | Enhancers | Fetal Intestine Small | intestine |
8 | chr8:63595000-63595400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr8:63595000-63595400 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
10 | chr8:63595000-63595400 | Enhancers | Left Ventricle | heart |
11 | chr8:63595000-63596400 | Enhancers | Stomach Mucosa | stomach |
12 | chr8:63595400-63596400 | Weak transcription | Left Ventricle | heart |
13 | chr8:63595400-63596400 | Weak transcription | Right Atrium | heart |
14 | chr8:63595400-63596600 | Enhancers | Duodenum Mucosa | Duodenum |
15 | chr8:63595400-63596600 | Enhancers | Hela-S3 | cervix |
16 | chr8:63596200-63596600 | Enhancers | Psoas Muscle | Psoas |
17 | chr8:63596400-63596600 | Enhancers | Left Ventricle | heart |
18 | chr8:63596400-63596600 | Enhancers | Right Atrium | heart |